Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor and
remains a fatal malignancy in the majority of patients. Approximately 20%–30% of patients …

The incidence of intrahepatic cholangiocarcinoma (iCCA) is increasing worldwide. Although
several advances have been made in the past decades to better understand this complex …

Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …

The American Joint Committee on Cancer (AJCC) Staging Manual represents the standard
for classifying patients with pancreas and hepatobiliary cancers, predicting prognosis, and …

Primary liver cancer—including hepatocellular carcinoma (HCC) and intrahepatic
cholangiocarcinoma (ICC)—incidence is increasing and is an important source of cancer …

Abstract An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus
meeting of expert panellists met on 15 January 2014 to review current evidence on the …

Liver cirrhosis, the end-stage of every chronic liver disease, is not only the major risk factor
for the development of hepatocellular carcinoma but also a limiting factor for anticancer …

Intrahepatic cholangiocarcinoma (ICC) is the second most common malignancy arising from
the liver. ICC makes up about 10% of all cholangiocarcinomas. It arises from the peripheral …

BACKGROUND A patient can be considered statistically cured from a specific disease when
their mortality rate returns to the same level as that of the general population. In the current …

Molecular variation between geographical populations and subtypes indicate potential
genomic heterogeneity and novel genomic features within CCA. Here, we analyze exome …